Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Assets: 2014-2024

Historic Assets for Surgery Partners (SGRY) over the last 10 years, with FY2024 value amounting to $7.9 billion.

  • Surgery Partners' Assets rose 547.09% to $7.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $31.7 billion, marking a year-over-year increase of 992.3%. This contributed to the annual value of $7.9 billion for FY2024, which is 1473.53% up from last year.
  • Per Surgery Partners' latest filing, its Assets stood at $7.9 billion for FY2024, which was up 1473.53% from $6.9 billion recorded in FY2023.
  • In the past 5 years, Surgery Partners' Assets registered a high of $7.9 billion during FY2024, and its lowest value of $5.4 billion during FY2020.
  • Over the past 5 years, Surgery Partners' median Assets value was $6.7 billion (recorded in 2022), while the average stood at $6.6 billion.
  • In the last 5 years, Surgery Partners' Assets skyrocketed by 291.23% in 2023 and then skyrocketed by 1473.53% in 2024.
  • Annual analysis of 5 years shows Surgery Partners' Assets stood at $5.4 billion in 2020, then grew by 13.01% to $6.1 billion in 2021, then grew by 9.23% to $6.7 billion in 2022, then increased by 2.91% to $6.9 billion in 2023, then increased by 14.74% to $7.9 billion in 2024.
  • Its Assets was $7.9 billion in FY2024, compared to $6.9 billion in FY2023 and $6.7 billion in FY2022.